Welcome to World Journal of Clinical Oncology

 

The World Journal of Clinical Oncology (WJCO) is a leading academic journal devoted to reporting the latest, cutting-edge research progress and findings of basic research and clinical practice in the field of oncology.  It was launched on November 10, 2010 and is published trimonthly (6 issues annually) by BPG, the world's leading professional clinical medical journal publishing company.

 

We encourage oncologists worldwide to submit manuscripts to the WJCO describing their original basic or clinical research findings that are of high academic value and which report new diagnostic techniques or summarize their treatment experiences.

 

The usual times related to all publication processes of the WJCO are as follows: from manuscript receipt to peer review: 2-4 weeks; from initial manuscript acceptance, with revisions, to return of the revised manuscript from the authors: 4-5 weeks; from return of the revised manuscript from the authors to final acceptance: 1-2 weeks; from final acceptance to an article in press: 2 days; from article in press designation to formal release of the electronic version and all online documentation: 2-9 weeks. The WJCO’s acceptance rate: 55%. Submit here >>

Published Issues
1
Editors-in-Chief

Stuart Calderwood, PhD, Professor; Timothy Pawlik, MD, Director, Professor; Dimitrios Roukos, MD, PhD, Professor

Indexing/Abstracting

PubMed, PubMed Central.

Impact Factor

There is currently no impact factor.

ISSN

2218-4333 (online)

Previous  |   Next  |   Latest  |   Archive
Contents Volume 7  Issue 1  February 10, 2016
Editorial
Neoadjuvant treatment for resectable pancreatic adenocarcinoma  
John Wong, Naveenraj L Solomon, Chung-Tsen Hsueh
World J Clin Oncol 7(1):1-8. Published online Feb 10, 2016. doi: 10.5306/wjco.v7.i1.1
Current treatment options for patients with initially unresectable isolated colorectal liver metastases  
Ozkan Kanat
World J Clin Oncol 7(1):9-14. Published online Feb 10, 2016. doi: 10.5306/wjco.v7.i1.9
Review
Advanced oropharyngeal squamous cell carcinoma: Pathogenesis, treatment, and novel therapeutic approaches  
Paul L Swiecicki, Kelly M Malloy, Francis P Worden
World J Clin Oncol 7(1):15-26. Published online Feb 10, 2016. doi: 10.5306/wjco.v7.i1.15
Current therapeutic strategies for advanced pancreatic cancer: A review for clinicians  
Rosella Spadi, Federica Brusa, Agostino Ponzetti, Isabella Chiappino, Nadia Birocco, Libero Ciuffreda, Maria Antonietta Satolli
World J Clin Oncol 7(1):27-43. Published online Feb 10, 2016. doi: 10.5306/wjco.v7.i1.27
Current status of ultrasound-guided surgery in the treatment of breast cancer  
José H Volders, Max H Haloua, Nicole MA Krekel, Sybren Meijer, Petrousjka M van den Tol
World J Clin Oncol 7(1):44-53. Published online Feb 10, 2016. doi: 10.5306/wjco.v7.i1.44
Historical review of the causes of cancer  
Clarke Brian Blackadar
World J Clin Oncol 7(1):54-86. Published online Feb 10, 2016. doi: 10.5306/wjco.v7.i1.54
Overview, prevention and management of chemotherapy extravasation  
Firas Y Kreidieh, Hiba A Moukadem, Nagi S El Saghir
World J Clin Oncol 7(1):87-97. Published online Feb 10, 2016. doi: 10.5306/wjco.v7.i1.87
Minireviews
Intensive care outcomes in adult hematopoietic stem cell transplantation patients  
Ulas D Bayraktar, Joseph L Nates
World J Clin Oncol 7(1):98-105. Published online Feb 10, 2016. doi: 10.5306/wjco.v7.i1.98
Role of copper transporters in platinum resistance  
Deepak Kilari, Elizabeth Guancial, Eric S Kim
World J Clin Oncol 7(1):106-113. Published online Feb 10, 2016. doi: 10.5306/wjco.v7.i1.106
Recent advances in microvascular autologous breast reconstruction after ablative tumor surgery  
Michael S Pollhammer, Dominik Duscher, Manfred Schmidt, Georg M Huemer
World J Clin Oncol 7(1):114-121. Published online Feb 10, 2016. doi: 10.5306/wjco.v7.i1.114
Targeting metabolism in breast cancer: How far we can go?  
Jing-Pei Long, Xiao-Na Li, Feng Zhang
World J Clin Oncol 7(1):122-130. Published online Feb 10, 2016. doi: 10.5306/wjco.v7.i1.122